Oxolan-3-amine → 5-(4-((S)-1-(2-(3-(difluoromethyl)-4,4,7,7-tetrafluoro-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetamido)-2-(3,5-difluorophenyl)ethyl)-2-((tetrahydrofuran-3-yl)amino)pyrimidin-5-yl)-2-fluorobenzamide
Reaction equation
N1([CH2:6][CH2:7][NH:8][C:9]2[N:14]=[C:13]([C@@H:15]([NH:25][C:26](=[O:44])[CH2:27][N:28]3[C:36]4[C:35]([F:38])([F:37])[CH2:34][CH2:33][C:32]([F:40])([F:39])[C:31]=4[C:30]([CH:41]([F:43])[F:42])=[N:29]3)[CH2:16][C:17]3[CH:22]=[C:21]([F:23])[CH:20]=[C:19]([F:24])[CH:18]=3)[C:12]([C:45]3[CH:46]=[CH:47][C:48]([F:54])=[C:49]([CH:53]=3)[C:50]([NH2:52])=[O:51])=[CH:11][N:10]=2)C=CN=N1.[O:55]1CC[CH:57](N)[CH2:56]1.BrC1C([C@@H](NC(=O)OC(C)(C)C)CC2C=C(F)C=C(F)C=2)=NC(S(C)(=O)=O)=NC=1>>[F:43][CH:41]([F:42])[C:30]1[C:31]2[C:32]([F:40])([F:39])[CH2:33][CH2:34][C:35]([F:37])([F:38])[C:36]=2[N:28]([CH2:27][C:26]([NH:25][C@H:15]([C:13]2[C:12]([C:45]3[CH:46]=[CH:47][C:48]([F:54])=[C:49]([CH:53]=3)[C:50]([NH2:52])=[O:51])=[CH:11][N:10]=[C:9]([NH:8][CH:7]3[CH2:57][CH2:56][O:55][CH2:6]3)[N:14]=2)[CH2:16][C:17]2[CH:22]=[C:21]([F:23])[CH:20]=[C:19]([F:24])[CH:18]=2)=[O:44])[N:29]=1Participants
4
Reactant 3
Product 1
Procedure
The title compound (25) was prepared according to the method presented for the synthesis of compound 23F of Example 23 starting with tetrahydrofuran-3-amine and 23B. 1H NMR (400 MHz, CD3OD) δ 8.71 (d, J=7.6 Hz, 1H), 8.06 (s, 1H), 7.43-7.26 (m, 2H), 7.24-7.14 (m, 1H), 6.95-6.63 (m, 2H), 6.42 (d, J=5.9 Hz, 2H), 5.22 (m, 1H), 5.04 (s, 2H), 4.66 (m, 1H), 4.01 (m, 2H), 3.93-3.84 (m, 1H), 3.76 (m, 1H), 3.02 (m, 2H), 2.51 (m, 4H), 2.37 (m, 1H), 1.99 (m, 1H). MS (m/z) 742.15 [M+H]+.
Sources & evidence
- ORD record
- ord-b062388ddf6c42aebbe6291c11e69051
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09050344B2
Reaction notes
Loading…